Noted health economist Uwe Reinhardt, in a JAMA viewpoint, suggests that price transparency is a "disruptive innovation" for health care, particularly when linked to reference pricing. This assumes, however, that patients are more interested in price than in a relationship with a particular doctor, and that consumers have sufficient incentives to care about price.
http://jama.jamanetwork.com/article.aspx?articleid=1769895A Congressional Budget Office report tackles the difficult subject of growing military health spending, providing options to reduce the rate of increase.
Read More
A perspective in the New England Journal of Medicine suggests that application of the Medicare value-based purchasing program to hospitals serving more disadvantages patients punishes them financially, reducing their resources to improve care, which hopefully is an unintended consequence.
http://www.nejm.org/doi/full/10.1056/NEJMp1312654The IMS Institute for Healthcare Informatics issues a report describing the efforts of pharmaceutical manufacturers to use social media to engage patients.
Read More
